Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Income 1 Regulatory News (MIG1)

Share Price Information for Maven Income 1 (MIG1)

Share Price is delayed by 15 minutes
Get Live Data
33.80    0.00 (0.00%)
Bid:
32.80
Ask:
34.80
Spread: 2.00 (6.098%)
Market Cap: £70.05m
MIG1 Live PriceLast checked at - London Stock Exchange

Intraday Maven Income 1 Share Chart

Statement re Offer for Subscription

30 Apr 2014 07:01

RNS Number : 8455F
Maven Income & Growth VCT PLC
30 April 2014
 



Maven Income and Growth VCT plc (the "Company")

 

Extension to Offer for Subscription

 

On 24 October 2013, the Company, Maven Income and Growth VCT 2 plc, Maven Income and Growth VCT 3 plc, Maven Income and Growth VCT 4 plc, Maven Income and Growth VCT 5 plc and Maven Income and Growth VCT 6 plc (together "the Companies") announced that they had published a Prospectus (comprising a Securities Note, Registration Document and Summary) in relation to offers for subscription for new Ordinary Shares in each of the Companies to raise, in aggregate, up to £20 million (before issue costs) together with an over-allotment facility for up to a further £5 million, in aggregate (the "Offer").

 

The Offer closed on 5 April 2014 in relation to the tax year 2013/14 and was intended to close on 30 April 2014 in relation to the tax year 2014/15 unless fully subscribed by an earlier date or previously extended by the directors of the Company (the "Directors") to no later than 30 September 2014.

 

The Finance Bill 2014 (the "Bill"), published on 27 March 2014, contained proposed changes to regulations which would apply to VCT shares issued on or after 6 April 2014. The Directors have been advised that certain provisions of the Bill are ambiguous and, if an allotment were to be made subsequent to 6 April 2014, could be interpreted in a manner that would have serious and adverse tax consequences for all Shareholders. Although HM Treasury have acknowledged the concerns made by the VCT industry regarding these provisions, and have agreed that amendments will be made to them, the relevant amendments have not yet been published. Any amendments will also be subject to Parliamentary review and debate.

 

Therefore, in the interest of all of the Company's Shareholders, the Directors have decided to postpone any allotment of new Ordinary Shares under the Offer for the 2014/15 tax year, with applications (and application monies) held pending until the Directors believe that there is certainty that allotments can take place without contravening the new rules. At such time when the Directors have been advised that the allotments can be made without adverse effects on the status and operation of the Company, an appropriate announcement will be made.

 

Given that the Directors intended to allot Ordinary Shares for the tax year 2014/15 before the end of April 2014, it was the expectation that all new investors under the Offer would be eligible to receive the final dividend from the Company for the year ended 28 February 2014. However, in view of the above, it is possible that any further allotment of new Ordinary Shares may now take place after the record date for this dividend, in which case the Offer Price will be adjusted under the Pricing Formula for the Offer and will reflect that no dividend payment will be received.

 

In view of the above, the Offer has been extended to 5.00 pm on 30 September 2014 or such earlier date on which the Offer is fully subscribed or on which the directors of the Companies may resolve to close the Offer. In relation to this issue, it is also proposed that a Supplementary Prospectus will be submitted to the UKLA for approval, at which point a further announcement will be made.

 

Any enquiries in respect of this extension to the Offer should be directed to:

 

Maven Capital Partners UK LLP:

Telephone: 0141 306 7400

E-mail: enquiries@mavencp.com

 

Maven Capital Partners UK LLP

Secretary

 

30 April 2014

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRFKLLLZZFFBBD
Date   Source Headline
7th Mar 20195:50 pmRNSIssue of Equity
4th Mar 201912:40 pmRNSNet Asset Value(s)
28th Jan 20195:18 pmRNSTransaction in Own Shares
24th Jan 20194:31 pmRNSNet Asset Value(s)
23rd Jan 20197:00 amRNSOffer for Subscription
29th Nov 201810:37 amRNSDirectorate Change
5th Nov 20185:10 pmRNSTransaction in Own Shares
2nd Nov 201811:32 amRNSResult of General Meeting
26th Oct 20187:00 amRNSHalf-year Report
12th Oct 20184:36 pmRNSNet Asset Value
26th Sep 20186:29 pmRNSStatement re Offer for Subscription
18th Jul 20187:00 amRNSStatement re Offer for Subscription
6th Jul 201811:45 amRNSNet Asset Value(s)
5th Jul 20182:38 pmRNSResult of AGM
1st Jun 20184:59 pmRNSAnnual Financial Report
22nd May 20182:47 pmRNSHolding(s) in Company
21st May 20185:22 pmRNSTransaction in Own Shares
17th May 20184:30 pmRNSDividend Declaration
25th Apr 20185:20 pmRNSTransaction in Own Shares
24th Apr 20184:46 pmRNSNet Asset Value(s)
8th Mar 20183:30 pmRNSDividend Declaration
1st Feb 20184:17 pmRNSNet Asset Value and Interim Dividend
28th Nov 20172:42 pmRNSHalf-year Report
22nd Nov 20175:04 pmRNSTransaction in Own Shares
10th Nov 201712:08 pmRNSNet Asset Value(s)
25th Oct 20172:55 pmRNSDividend Declaration
31st Aug 20175:17 pmRNSTransaction in Own Shares
6th Jul 20172:19 pmRNSNet Asset Value(s)
6th Jul 20172:08 pmRNSResult of AGM
15th Jun 20174:00 pmRNSDividend Declaration
2nd Jun 20174:02 pmRNSAnnual Financial Report
25th Apr 20174:57 pmRNSStatement re NAV and Interim Dividend
27th Jan 201712:01 pmRNSNet Asset Value(s)
9th Nov 20163:53 pmRNSDirector/PDMR Shareholding
8th Nov 20164:50 pmRNSTransaction in Own Shares
28th Oct 20167:00 amRNSHalf-year Report
17th Oct 201610:17 amRNSNet Asset Value and Interim Dividend
18th Jul 20164:24 pmRNSTransaction in Own Shares
7th Jul 20161:59 pmRNSResult of AGM
7th Jul 20161:58 pmRNSNet Asset Value(s)
3rd Jun 20164:10 pmRNSAnnual Financial Report
26th Apr 20164:05 pmRNSNet Asset Value and Dividend Declarations
23rd Feb 20164:52 pmRNSTransaction in Own Shares
10th Feb 20163:39 pmRNSForm 8.3 - Tangent Communications PLC
5th Feb 20163:06 pmRNSTransaction in Own Shares
4th Feb 20164:53 pmRNSTransaction in Own Shares
22nd Jan 201610:28 amRNSNet Asset Value(s)
9th Dec 20154:15 pmRNSPortfolio Update and Unaudited Net Asset Value
27th Oct 20151:15 pmRNSHalf Yearly Report
9th Oct 201510:43 amRNSStatement re Net Asset Value and Interim Dividend

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.